These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8300038)
1. HIV prevalence and risk behaviour in injecting drug users in Berlin. Stark K; Müller R Forensic Sci Int; 1993 Nov; 62(1-2):73-81. PubMed ID: 8300038 [TBL] [Abstract][Full Text] [Related]
2. Determinants of HIV infection and recent risk behaviour among injecting drug users in Berlin by site of recruitment. Stark K; Müller R; Wirth D; Bienzle U; Pauli G; Guggenmoos-Holzmann I Addiction; 1995 Oct; 90(10):1367-75. PubMed ID: 8616465 [TBL] [Abstract][Full Text] [Related]
3. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin. Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I J Epidemiol Community Health; 1996 Oct; 50(5):534-7. PubMed ID: 8944860 [TBL] [Abstract][Full Text] [Related]
4. Determinants of current HIV risk behaviour among injecting drug users in Warsaw, Poland. Stark K; Sieroslawski J; Müller R; Wirth D; Godwod-Sikorska C; Bienzle U Eur J Epidemiol; 1996 Jun; 12(3):315-7. PubMed ID: 8884201 [TBL] [Abstract][Full Text] [Related]
5. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users. Schlumberger MG; Desenclos JC; Papaevangelou G; Richardson SC; Ancelle-Park R Eur J Epidemiol; 1999 Mar; 15(3):207-15. PubMed ID: 10395049 [TBL] [Abstract][Full Text] [Related]
6. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418 [TBL] [Abstract][Full Text] [Related]
7. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur. Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497 [TBL] [Abstract][Full Text] [Related]
8. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States. Vanichseni S; Des Jarlais DC; Choopanya K; Friedmann P; Wenston J; Sonchai W; Sotheran JL; Raktham S; Carballo M; Friedman SR AIDS; 1993 Jun; 7(6):887-91. PubMed ID: 8363764 [TBL] [Abstract][Full Text] [Related]
9. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671 [TBL] [Abstract][Full Text] [Related]
10. Behavioural risk factors and HIV infection of injection drug users at detoxification clinics in Puerto Rico. Robles RR; Colón HM; Díaz N; Cancel LI; MacGowan R; Cole GE; Allen DM Int J Epidemiol; 1994 Jun; 23(3):595-601. PubMed ID: 7960388 [TBL] [Abstract][Full Text] [Related]
11. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users. Hartgers C; van Ameijden EJ; van den Hoek JA; Coutinho RA Public Health Rep; 1992; 107(6):675-81. PubMed ID: 1454980 [TBL] [Abstract][Full Text] [Related]
12. Low and stable prevalence of HIV among drug injectors in Glasgow. Taylor A; Frischer M; Green ST; Goldberg D; McKeganey N; Gruer L Int J STD AIDS; 1994; 5(2):105-7. PubMed ID: 8031910 [TBL] [Abstract][Full Text] [Related]
13. Injecting drug use and HIV infection in southwest China. Zheng X; Tian C; Choi KH; Zhang J; Cheng H; Yang X; Li D; Lin J; Qu S; Sun X AIDS; 1994 Aug; 8(8):1141-7. PubMed ID: 7986413 [TBL] [Abstract][Full Text] [Related]
14. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India. Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303 [TBL] [Abstract][Full Text] [Related]
15. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow. Rhodes TJ; Bloor MJ; Donoghoe MC; Haw S; Ettore B; Platt S; Frischer M; Hunter GM; Taylor A; Finlay A AIDS Care; 1993; 5(4):413-25. PubMed ID: 8110856 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of users of syringe vending machines in Berlin. Stark K; Leicht A; Müller R Soz Praventivmed; 1994; 39(4):209-16. PubMed ID: 7941771 [TBL] [Abstract][Full Text] [Related]
17. Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran. Mehrjerdi ZA; Abarashi Z; Noroozi A; Arshad L; Zarghami M Int J STD AIDS; 2014 May; 25(6):420-7. PubMed ID: 24287028 [TBL] [Abstract][Full Text] [Related]
18. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India. Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G; AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480 [TBL] [Abstract][Full Text] [Related]
19. Drug use and HIV risk-taking behaviour among injecting drug users not currently in treatment in Sydney, Australia. Baker A; Kochan N; Dixon J; Wodak A; Heather N Drug Alcohol Depend; 1994 Jan; 34(2):155-60. PubMed ID: 8026303 [TBL] [Abstract][Full Text] [Related]
20. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group. Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]